CG
IMGN

Cutler Group’s Immunogen Inc IMGN Stock Holding History

Cutler Group’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-6,800
Closed -$36K – 3955
2023
Q4 		$36K Buy
6,800
+6,300
+1,260% +$125K ﹤0.01% 1644
2023
Q3 		$3K Sell
500
-7,800
-94% -$130K ﹤0.01% 3201
2023
Q2 		$65K Buy
8,300
+5,200
+168% +$61.4K 0.01% 1161
2023
Q1 		$2K Buy
+3,100
New +$13.2K ﹤0.01% 3299
2022
Q3 		– Sell
-3,300
Closed -$3K – 5705
2022
Q2 		$3K Buy
+3,300
New +$14.3K ﹤0.01% 4165
2022
Q1 		– Sell
-15,000
Closed -$10K – 6273
2021
Q4 		$10K Buy
+15,000
New +$93.2K ﹤0.01% 3739
2017
Q4 		– Sell
-29,500
Closed -$28K – 6181
2017
Q3 		$28K Buy
29,500
+27,000
+1,080% +$179K ﹤0.01% 2815
2017
Q2 		$6K Sell
2,500
-40,100
-94% -$183K ﹤0.01% 4724
2017
Q1 		$50K Buy
+42,600
New +$124K ﹤0.01% 2417

Other funds holding IMGN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $10B AUM 15.14% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Cutler Group's IMGN Position: Q1 2024 in Review

Cutler Group sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 3,900 shares — an estimated $115K sold.

Cutler Group first reported a position in IMGN in Q1 2016 and held it in 19 quarters. The position peaked at $136K in Q4 2022. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

  • Cutler Group reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
  • Cutler Group sold 3,900 Immunogen Inc shares in Q1 2024, an estimated $115K.
  • Cutler Group first reported a position in Immunogen Inc in Q1 2016 and held it in 19 quarters.
  • Cutler Group's Immunogen Inc position peaked at $136K in Q4 2022.
  • 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on Cutler Group's 13F filing for Q1 2024, filed 19 Apr 2024.